Laura Tassi Selected Research

Laura Tassi Research Topics

Disease

16	Epilepsy (Aura) 04/2022 - 01/2002
15	Seizures (Absence Seizure) 12/2022 - 09/2003
13	Partial Epilepsies (Epilepsy, Partial) 11/2023 - 09/2003
6	Focal Cortical Dysplasia 10/2020 - 09/2003
6	Drug Resistant Epilepsy 01/2020 - 09/2003
4	Status Epilepticus (Complex Partial Status Epilepticus) 02/2022 - 07/2016
3	Temporal Lobe Epilepsy 07/2016 - 06/2006
3	Malformations of Cortical Development 09/2006 - 09/2003
2	Cerebral Hemorrhage 01/2024 - 10/2005
2	Central Nervous System Cavernous Hemangioma 01/2024 - 05/2009
2	Familial cerebral cavernous malformation 12/2023 - 05/2020
2	Epilepsia Partialis Continua 02/2022 - 09/2013
2	Disease Progression 05/2020 - 11/2015
2	Spasm (Spasms) 01/2018 - 01/2017
2	Periventricular Nodular Heterotopia 09/2006 - 01/2002
1	Stroke (Strokes) 04/2022
1	Intellectual Disability (Idiocy) 02/2022
1	Diarrhea 01/2021
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021
1	Lennox Gastaut Syndrome 01/2021
1	Sleepiness 01/2021
1	COVID-19 08/2020
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Atrophy 01/2018
1	Tuberous Sclerosis (Bourneville's Disease) 01/2018
1	Epileptic Syndromes 01/2018
1	Brain Injuries (Brain Injury) 09/2017
1	Hashimoto's encephalitis 03/2017
1	Myoclonus (Nocturnal Myoclonus) 03/2017
1	Hallucinations (Hallucination) 03/2017
1	Brain Diseases (Brain Disorder) 03/2017
1	Tremor (Tremors) 03/2017
1	Ataxia (Dyssynergia) 03/2017
1	Cognitive Dysfunction 03/2017
1	Posterior Leukoencephalopathy Syndrome 07/2016
1	Biliary Atresia 07/2016
1	Anxiety Disorders (Anxiety Disorder) 10/2015
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 08/2013
1	Classical Lissencephalies and Subcortical Band Heterotopias 09/2006
1	Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor) 11/2003
1	Ganglioglioma 06/2002
1	Choristoma (Ectopic Tissue) 01/2002

Drug/Important Bio-Agent (IBA)

7	brivaracetamIBA 11/2023 - 12/2021
5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 08/2013
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2017
2	Propranolol (Inderal)FDA LinkGeneric 01/2024 - 05/2020
2	trans-sodium crocetinate (crocetin)IBA 04/2022 - 01/2018
2	erucylphosphocholineIBA 02/2022 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2006
2	bis(tri- n- hexylsiloxy)(2,3- naphthalocyaninato)silicon (SINC)IBA 09/2020 - 08/2020
2	ParvalbuminsIBA 01/2016 - 06/2006
2	gamma-Aminobutyric Acid (GABA)IBA 01/2016 - 06/2006
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2006 - 01/2002
1	CannabidiolIBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	ParaffinIBA 10/2020
1	Formaldehyde (Formol)FDA Link 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Temazepam (Nocturne)FDA LinkGeneric 01/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2019
1	CytokinesIBA 01/2018
1	Kainic Acid (Kainate)IBA 01/2018
1	AntibodiesIBA 03/2017
1	PotassiumIBA 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2016
1	MTOR InhibitorsIBA 11/2015
1	ChromatinIBA 11/2015
1	TOR Serine-Threonine KinasesIBA 11/2015
1	Carbamazepine (Tegretol)FDA LinkGeneric 10/2015
1	Levetiracetam (Keppra)FDA LinkGeneric 10/2015
1	2,6-dinitrotoluene (DNT)IBA 06/2002

Therapy/Procedure

12	Electrodes (Electrode) 12/2021 - 01/2002
6	Therapeutics 01/2022 - 09/2003
2	Electrocoagulation (Electrocautery) 10/2016 - 12/2015
1	Hemispherectomy 02/2021
1	Implanted Electrodes 01/2021
1	Protective Devices (Safety Device) 08/2020
1	Injections 01/2018
1	Operative Surgical Procedures 01/2017
1	Liver Transplantation 07/2016
1	Ketogenic Diet 11/2015
1	Vagus Nerve Stimulation 09/2013
1	Ligation 05/2009